Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

545
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
545
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

630
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
630
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

953
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
953
Guidelines for Sketching a Curve01:23

Guidelines for Sketching a Curve

151
Curve sketching is a systematic method for understanding the overall behavior of a function by analyzing its key mathematical features. A function defines a curve on the coordinate plane, where the horizontal axis represents the input variable and the vertical axis represents the output. The process begins by determining the domain, which specifies the set of input values for which the function is defined and establishes the horizontal extent of the graph.Intercepts with the horizontal and...
151
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

4.0K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
4.0K
Guidelines for Nursing Documentation I01:30

Guidelines for Nursing Documentation I

2.0K
Quality documentation and reporting share essential characteristics that ensure they are practical and valuable resources for those who use them. These characteristics are:
Factual:  
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness and safety of enfortumab vedotin and pembrolizumab in a real-world patient population with urothelial carcinoma: results from a multi-institutional cohort (GUARDIANS).

Cancer immunology, immunotherapy : CII·2026
Same author

Baseline Sarcopenia is Associated With Overall Survival but Not Toxicity in Patients Receiving Enfortumab Vedotin Plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma.

Clinical genitourinary cancer·2026
Same author

Longitudinal circulating tumour DNA identifies patients at high risk of upstaging and recurrence in non-muscle-invasive bladder cancer.

BJU international·2026
Same author

Trophoblastic-Differentiated Urothelial Carcinoma: Real-World Sequencing and Clinical Implications.

Clinical genitourinary cancer·2026
Same author

Emerging Intravesical Therapies for Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same author

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026

Related Experiment Video

Updated: Feb 11, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

5.5K

ASO Practice Guidelines Series: Surgical Management of Bladder Cancer Relapse.

Can Aydogdu1, Sean T McSweeney1, Vignesh T Packiam2

  • 1Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.

Annals of Surgical Oncology
|February 10, 2026
PubMed
Summary

Managing recurrent bladder cancer after bacillus Calmette-Guérin (BCG) or trimodal therapy (TMT) requires balancing cure with quality of life. Early radical cystectomy is often recommended, with bladder-sparing options available for select patients.

More Related Videos

An Orthotopic Model of Murine Bladder Cancer
09:07

An Orthotopic Model of Murine Bladder Cancer

Published on: February 6, 2011

16.5K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.1K

Related Experiment Videos

Last Updated: Feb 11, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

5.5K
An Orthotopic Model of Murine Bladder Cancer
09:07

An Orthotopic Model of Murine Bladder Cancer

Published on: February 6, 2011

16.5K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.1K

Area of Science:

  • Urology
  • Oncology
  • Cancer Research

Background:

  • Recurrent bladder cancer after initial treatments like bacillus Calmette-Guérin (BCG) or trimodal therapy (TMT) presents complex treatment challenges.
  • Patients with high-risk non-muscle-invasive or muscle-invasive bladder cancer require timely decisions balancing oncologic outcomes with quality of life.

Purpose of the Study:

  • To translate current guidelines and pivotal trial data into practical decision-making strategies for managing bladder cancer recurrence.
  • To provide clinicians and patients with a clear framework for navigating treatment options after BCG or TMT failure.

Main Methods:

  • Review of 2024-2025 guidelines from major urological and oncological societies (AUA/SUO, NCCN, EAU).
  • Incorporation of data from pivotal clinical trials and recent US Food and Drug Administration (FDA)-approved drug advancements.
  • Emphasis on practical application for clinical decision-making and patient counseling.

Main Results:

  • For post-BCG recurrence, radical cystectomy (RC) is the primary recommendation for cure in medically fit patients; bladder-sparing therapies with strict surveillance are alternatives.
  • Following TMT, RC is standard for invasive relapse, while bladder preservation is considered for select noninvasive cases.
  • Optimal management in both scenarios necessitates prompt evaluation, comprehensive option presentation, and multidisciplinary input with close follow-up.

Conclusions:

  • Effective management of bladder cancer recurrence hinges on aligning treatment with patient goals and safeguarding oncologic outcomes.
  • Early involvement of multidisciplinary teams and shared decision-making are crucial for optimizing patient care and outcomes.